Impact of Race on the Outcomes of Retinoblastoma Treated With Primary Enucleation: A Global Study of 1426 Patients
Open Access
- 28 December 2024
- journal article
- research article
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 53 (4) , 421-434
Abstract
Background: To evaluate the clinical presentation, pathological features and outcomes of retinoblastoma based on the race of origin in a global cohort of patients.Methods: Retrospective collaborative study of 1426 patients who underwent primary enucleation for retinoblastoma.Results: Patients were grouped into Caucasians (n = 231, 16%), Asians (n = 841, 59%), Hispanics (n = 226, 16%), Arabs (n = 96, 7%) and Others (Africans, African Americans, Indigenous Australians; n = 32, 2%) cohorts. On histopathology, massive choroidal invasion was higher in Asians (30%) and Hispanics (26%) than Caucasians (15%, p < 0.001). Post‐laminar optic nerve invasion was higher in Asians (28%), Hispanics (20%) and Others (9%) than Caucasians (11%, p < 0.001). At a mean follow‐up of 41 months (median, 35 months; range, < 1–149 months), tumour recurrence and metastasis‐related death was higher in Hispanics (9% and 12%, respectively), Asians (4% and 13%, respectively) and Others (6% and 6%, respectively). Multivariate Cox proportional hazards analysis of outcomes based on race with 8th edition AJCC pT stage and adjuvant therapy as covariates revealed 6.8 times greater risk for orbital tumour recurrence in Hispanics compared to Caucasians (p = 0.010) and 3.2 times risk hazards for metastasis‐related death in Hispanics and Asians compared to Caucasians (p = 0.028 and p = 0.038, respectively).Conclusion: The histopathological features in primarily enucleated eyes with retinoblastoma vary with race. Despite adjusting for tumour staging and adjuvant treatment, race remains an independent predictor of outcomes, including orbital tumour recurrence and metastasis‐related death. A stringent follow‐up and a more aggressive treatment approach is recommended in Asians and Hispanics who manifest high‐risk histopathological features.Keywords
Funding Information
- Hyderabad Eye Research Foundation
This publication has 31 references indexed in Scilit:
- Trends in Cancer Mortality Disparities Between Black and White Individuals in the US, 2000-2020JAMA Health Forum, 2024
- Trends in Cancer Mortality Among Black Individuals in the US From 1999 to 2019JAMA Oncology, 2022
- Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversityClinical & Experimental Metastasis, 2021
- Racial/ethnic differences in survival among gastric cancer patients in californiaCancer Causes & Control, 2019
- Racial and Geographic Disparities in Hepatocellular Carcinoma OutcomesAmerican Journal of Preventive Medicine, 2018
- Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United StatesJAMA, 2015
- Racial Differences in the Presentation and Outcomes of Chronic Lymphocytic Leukemia and Variants in the United StatesClinical Lymphoma Myeloma and Leukemia, 2011
- Postenucleation Adjuvant Chemotherapy With Vincristine, Etoposide, and Carboplatin for the Treatment of High-Risk RetinoblastomaArchives of Ophthalmology (1950), 2011
- Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancerThe Prostate, 2010
- Intraocular Retinoblastoma: the Case for a New Group ClassificationOphthalmology Clinics of North America, 2005